Nassif David W. 4
4 · Sio Gene Therapies Inc. · Filed Feb 10, 2022
Insider Transaction Report
Form 4
Nassif David W.
Principal Financial Officer
Transactions
- Award
Restricted Stock Units
2022-02-08+546,500→ 546,500 total→ Common Stock (546,500 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the right to receive one share of the Issuer's common stock.
- [F2]One-third of the restricted stock units shall vest on February 8, 2023, February 8, 2024 and February 8, 2025, subject to the Reporting Person providing continuous service to the Issuer through each such date.